Synthesis and cytotoxicity studies of silyl-substituted titanocene dichloride derivatives

Organometallics

Volumn 31, Issue 16, 2012, Pages 5782-5790

  Deally, Anthony ^a   Hackenberg, Frauke ^a   Lally, Grainne ^a   Müller Bunz, Helge ^a   Tacke, Matthias ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINES; CYCLOPENTADIENES; CYCLOPENTADIENYLS; DIMETHYLSILANE; FULVENE; IN-VITRO TESTS; SUPERHYDRIDES; TITANIUM TETRACHLORIDES; TITANOCENE DICHLORIDE; TITANOCENES; TRANSMETALATION; TRIMETHYLSILYL;

CELL CULTURE; OLEFINS; X RAY CRYSTALLOGRAPHY;

TITANIUM;

EID: 84865473962     PISSN: 02767333     EISSN: 15206041     Source Type: Journal    
DOI: 10.1021/om300227h     Document Type: Article

References (42)

1. Sadler, P. J.; Guo, Z. Angew. Chem., Int. Ed. 1999, 38, 1512-1531
2. Frezza, M.; Hindo, S.; Chen, D.; Davenport, A.; Schmitt, S.; Tomco, D.; Dou, Q. P. Curr. Pharm. Des. 2010, 16, 1813-1825
3. Kostova, I. Recent Pat. Anti-Cancer Drug Discovery 2006, 1, 1-22
4. Köpf-Maier, P.; Köpf, H. Angew. Chem., Int. Ed. 1979, 18, 477-478
5. Köpf-Maier, P.; Klapötke, T.; Köpf, H.; Preiss, F.; Marx, T. Anticancer Res. 1986, 6, 33-37
6. Köpf-Maier, P.; Klapötke, T. Arzneim. Forsch. 1987, 37, 532-534
7. Köpf-Maier, P.; Hesse, B.; Köpf, H. J. Cancer Res. Clin. Oncol. 1980, 96, 43-51
8. Christodoulou, C. V.; Eliopoulos, A. G.; Young, L. S.; Hodgkins, L.; Ferry, D. R.; Kerr, D. J. Br. J. Cancer 1998, 77, 2088-2097
9. Berdel, W. E.; Schmoll, H. J.; Scheulen, M. E.; Korfel, A.; Knoche, M. F.; Harstrick, A.; Bach, F.; Baugmart, J.; Sab, G. Onkologie 1993, 16, 172-175
10. Korfel, A.; Scheulen, M. E.; Schmoll, H. J.; Gründel, O.; Harstrick, A.; Knoche, M.; Fels, L. M.; Skorzec, M.; Bach, F.; Baumgart, J.; Sab, G.; Seeber, S.; Thiel, E.; Berdel, W. E. Clin. Cancer Res. 1998, 4, 2701-2708
11. Lümmen, G.; Sperling, S.; Luboldt, H.; Otto, T.; Rübben, H. Cancer Chemother. Pharmacol. 1998, 42, 415-417
12. Kurbacher, C. M.; Nagel, W.; Mallmann, P.; Kurbacher, J. A.; Sass, G.; Hubner, H.; Andreotti, P. E.; Krebs, D. Anticancer Res. 1994, 14, 1529-1533
13. Allen, O. R.; Croll, L.; Gott, A. L.; Knox, R. J.; McGowan, P. C. Organometallics 2004, 23, 288-292
14. Allen, O. R.; Gott, A. L.; Hartley, J. A.; Hartley, J. M.; Knox, R. J.; McGowan, P. C. Dalton Trans. 2007, 5082-5090
15. Strohfeldt, K.; Tacke, M. Chem. Soc. Rev. 2008, 37, 1174-1187
16. Hogan, M.; Gleeson, B.; Tacke, M. Lett. Drug Des. Discovery 2010, 7, 310-317
17. Kelter, G.; Sweeney, N.; Strohfeldt, K.; Fiebig, H. H.; Tacke, M. Anti-Cancer Drugs 2005, 16, 1091-1098
18. Oberschmidt, O.; Hanauske, A. R.; Rehmann, F. J. K.; Strohfeldt, K.; Sweeney, N.; Tacke, M. Anti-Cancer Drugs 2005, 16, 1071-1073
19. Oberschmidt, O.; Hanauske, A. R.; Pampillón, C.; Sweeney, N. J.; Strohfeldt, K.; Tacke, M. Anti-Cancer Drugs 2007, 18, 317-321
20. O'Connor, K.; Gill, C.; Tacke, M.; Rehmann, F. J. K.; Strohfeldt, K.; Sweeney, N.; Fitzpatrick, J. M.; Watson, R. W. G. Apoptosis 2006, 11, 1205-1214
21. Valadares, M. C.; Ramos, A. L.; Rehmann, F. J. K.; Sweeney, N. J.; Strohfeldt, K.; Tacke, M.; Queiroz, M. L. S. Eur. J. Pharmacol. 2006, 534, 264-270
22. Weber, H.; Claffey, J.; Hogan, M.; Pampillón, C.; Tacke, M. Toxicol. In Vitro 2008, 22, 531-534
23. Fichtner, I.; Bannon, J.; O'Neill, A.; Pampillón, C.; Sweeney, N. J.; Strohfeldt, K.; Watson, R. W. G.; Tacke, M.; Mc Gee, M. M. Br. J. Cancer 2007, 97, 1234-1241
24. Fichtner, I.; Pampillón, C.; Sweeney, N. J.; Strohfeldt, K.; Tacke, M. Anti-Cancer Drugs 2006, 17, 333-336
25. Beckhove, P.; Oberschmidt, O.; Hanauske, A. R.; Pampillón, C.; Schirrmacher, V.; Sweeney, N. J.; Strohfeldt, K.; Tacke, M. Anti-Cancer Drugs 2007, 18, 311-315
26. Claffey, J.; Müller-Bunz, H.; Tacke, M. J. Organomet. Chem. 2010, 695, 2105-2117
27. Deally, A.; Gleeson, B.; Müller-Bunz, H.; Patil, S.; O'Shea, D. F.; Tacke, M. J. Organomet. Chem. 2011, 696, 1072-1083
28. Luan, X.; Wu, L.; Drinkel, E.; Mariz, R.; Gatti, M.; Dorta, R. Org. Lett. 2010, 12, 1912-1915
29. Vilsmeier, A.; Haack, A. Chem. Ber. 1927, 60, 119-122
30. Moyer, M.; Shiurba, J.; Rapoport, H. J. Org. Chem. 1986, 51, 5106-5110
31. Snyder, H.; Eliel, E. J. Am. Chem. Soc. 1948, 70, 1703-1705
32. Stone, K.; Little, R. J. Org. Chem. 1984, 49, 1849-1853
33. Sweeney, N; Gallagher, W. M.; Müller-Bunz, H.; Pampillón, C.; Strohfeldt, K.; Tacke, M. J. Inorg. Biochem. 2006, 100, 1479-1486
34. Deally, A.; Hackenberg, F.; Lally, G.; Tacke, M. Int. J. Med. Chem. 2012. DOI: 10.1155/2012/905981.
35. 4b: CrysalisPro, version 1.171.33.55; Oxford Diffraction Ltd.: Yarnton, England, 2010.
36. 4a: CrysalisPro, version 1.171.34.49; Agilent Technologies: Yarnton, England, 2011.
37. Sheldrick, G. M. Acta Crystallogr. 2008, A64, 112-122
38. Mossman, T. J. Immunol. Methods 1983, 65, 55-63
39. Olah, G. A.; Hunadi, R. J. J. Am. Chem. Soc. 1980, 102, 6989-6992
40. Landais, Y.; Rapado, P. Eur. J. Org. Chem. 2000, 401-418
41. Moreau, C.; Serein-Spireau, F.; Bordeau, M.; Biran, C. Organometallics 2001, 20, 1910-1917
42. Clive, D. L.; Cheng, H.; Gangopadhyay, P.; Huang, X.; Prabhudas, B. Tetrahedron 2004, 60, 4205-4221